Back to Results
First PageMeta Content
Division of Acquired Immunodeficiency Syndrome / National Institute of Allergy and Infectious Diseases / AIDS Clinical Trials Group / Antiretroviral drug / HIV / AIDS / Immunotherapy / Antiviral drug / Influenza / Medicine / Health / HIV/AIDS


Drug Research, NIAID Profile FY 2005
Add to Reading List

Document Date: 2012-07-10 11:34:53

Open Document

File Size: 109,25 KB

Share Result on Facebook

Company

Immunodeficiency Syndrome / GlaxoSmithKline / AIDS Clinical Trials Group / AIDS Clinical Trials Networks / NIH Clinical Center / /

Continent

Europe / /

Country

Canada / Australia / United States / /

Event

FDA Phase / Business Partnership / /

Facility

Blood Institute / University of Alabama / National Institute / NIAID National Institute of Allergy / National Institute of Allergy / NIH Clinical Center / Clinic To / U.S. Army Medical Research Institute / /

IndustryTerm

laboratory assay protocols / spectrometric technologies / pharmaceutical industry / immune system biochemical systems / treatment of infectious diseases / collaborative network / therapeutics clinical trial networks / AIDS prevention / chemical structures / manufacturing resources / HIV Therapies / treatment of infectious and immune-mediated diseases / clinical trials networks / natural products / clinical management / clinical research protocols / therapy of prion diseases / clinical trial networks / good diagnostic tools / of-the-art biological and chemical materials / diagnostic technologies / treatment of autoimmune diseases / therapies for asthma and allergic diseases / therapies for autoimmune diseases / chemical / /

MedicalCondition

inflammatory response / primary HIV infection / Scientific Research infections / HIV / arthritis / measles / rheumatoid arthritis / methicillin-resistant S. aureus / hepatitis B / viral respiratory infections / West Nile virus encephalitis / multiple sclerosis / CreutzfeldtJakob disease / chronic graft loss / similar disease / infectious and immunologic diseases / hepatitis / illness / liver disease / fungal infections / asthma / lethal inflammatory responses / pneumonia / allergic diseases / annual influenza / bacterial infections / malaria / fungal and parasitic infections / human infections / influenza A / diabetes / secondary infections / septicemia / viral infections / parainfluenza virus / immune system dysfunction / S. aureus / diseases / sexually transmitted infections / AIDS / HIV/AIDS / infectious and immune-mediated diseases / human viral infections / infection / fungal diseases / Sexually Transmitted Diseases / severe respiratory virus disease / systemic lupus erythematosus / inflammatory bowel disease / TB / genital herpes / strain / opportunistic and endemic mycoses / Acquired Immunodeficiency Syndrome / herpes / Infectious / avian flu virus / pneumonia virus / excessive inflammation / severe illness / avian influenza / eosinophilic gastroenteritis / community-acquired pneumonia / influenza virus / cowpox / infections / infectious agents / influenza / Sepsis / autoimmune diseases / HIV infection / severe human respiratory diseases / pulmonary Mycobacterium avium complex infection / bacteremia / opportunistic infections / lethal disease / herpes simplex viruses / disease / Ebola / Mycobacterium tuberculosis / acute respiratory distress syndrome / Division.of.Allergy / serious fungal diseases / prion diseases / HIV/ AIDS / mad cow disease / infectious diseases / early syphilis / vaccinia / malarial infections / chronic hepatitis C / Tuberculosis / severe respiratory virus infection / /

MedicalTreatment

kidney transplants / highly active antiretroviral therapy / clinical research protocols / kidney transplantation / antiviral therapies / antifungal therapies / HAART / antiretroviral therapy / antibiotics / chemotherapy / antiviral therapy / drug therapies / drug therapy / /

Organization

Division of Intramural Research / Kidney Diseases / Mycology Biostatistical and Operations Unit / National Heart / Lung / and Blood Institute / STD Clinical Trials Unit / Division of Allergy / Immunology / and Transplantation / National Institute of Allergy / NIAID’s mission / Scientific Research Division / University of Alabama at Birmingham / Division of Microbiology and Infectious Diseases / Division of Microbiology / National Institute of Health / Food and Drug Administration / Interagency Task Force on Antimicrobial Resistance / Digestive and Kidney Diseases / Public Health Service / Infectious Diseases / National Academy of Sciences / National Institute on Diabetes and Digestive / Centers for Disease Control and Prevention / NIAID Division / U.S. Army Medical Research Institute on Infectious Diseases / /

Position

RT / /

Product

Peginterferon / ribavirin / Xolair / sulfanilamide / leflunomide / penicillin / azithromycin / Research / /

ProvinceOrState

Alabama / /

Region

Middle East / Southeast Asia / West Nile / /

Technology

high-throughput screening / anti-infectives / drug discovery / laboratory assay protocols / DNA Chip / chemotherapy / combinatorial chemistry / Alpha / molecular modeling / Transplantation / http / drug design / drug development / 80 clinical research protocols / /

URL

www.taacf.org / www.aidsreagent.org / www.niaid / /

SocialTag